Research Articles | Page 24 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes Nov 2016 Leuk Res myelodysplastic syndromes (MDS)
Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: Ready for prime time? Jun 2012 Leuk Res myelodysplastic syndromes (MDS)
The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers Dec 2012 Leuk Res myelodysplastic syndromes (MDS)
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis Feb 2014 Leuk Res myelodysplastic syndromes (MDS)
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases Mar 2015 Leuk Res myelodysplastic syndromes (MDS)
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response Mar 2015 Leuk Res myelodysplastic syndromes (MDS)
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes Feb 2015 Leuk Res myelodysplastic syndromes (MDS)
Historical perspectives on myelodysplastic syndromes Aug 2012 Leuk Res myelodysplastic syndromes (MDS)
Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence Aug 2017 Leuk Res myelodysplastic syndromes (MDS)
Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016 Nov 2016 Leuk Res aplastic anemia
Share with addtoany.com.